文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

老年患者急诊离院时非特异性腹痛:频率、结局与不良事件危险因素(EDEN-43研究)

Non-specific abdominal pain in elderly patients discharged from the emergency department: Frequency, outcomes and risk-factors for adverse events (EDEN-43 study).
PubMed 文献 · Am J Emerg Med · 2025-04-03
一句话结论西班牙52家急诊一周内≥65岁离院患者中2.1%诊断为非特异性腹痛,30天联合不良事件22.9%,作者建议对合并症多、功能受限、需镇痛及未做实验室和影像检查者谨慎离院。

该研究纳入西班牙52家急诊科一周内所有≥65岁、诊断为非特异性腹痛并离院回家的患者,共397例(占同期离院老年患者的2.1%)。7天和30天全因死亡率分别为0.3%和1.5%,30天急诊再就诊率21.9%,30天住院率16.4%,30天联合不良事件(再就诊、住院或死亡)为22.9%。30天联合不良事件独立 associated with 合并症和功能受损(Barthel指数<100分;2.35,1.24-4.45)、使用阿片类(3.25,1.18-8.93)和非阿片类镇痛药(1.77,0.101-(Powers and Guertler, 1995 3).11)、以及急诊期间未做实验室检查(1.91,1.02-(Powers and Guertler, 1995 3).58)和未做影像检查(1.91,1.02-(Powers and Guertler, 1995 3).58);年龄、性别和延长急诊观察与不良事件风险无关。作者认为老年非特异性腹痛患者急诊离院应谨慎。

要点

  • 西班牙52家急诊一周内≥65岁离院患者中,非特异性腹痛占2.1%(397/19,026)。
  • 30天联合不良事件(急诊再就诊、住院或死亡)为22.9%。
  • 合并症和功能受损(Barthel指数<100分)与30天联合不良事件独立相关(2.35,1.24-4.45)。
  • 使用阿片类(3.25,1.18-8.93)和非阿片类镇痛药(1.77,0.101-(Powers and Guertler, 1995 3).11)与30天联合不良事件独立相关。
  • 急诊期间未做实验室检查(1.91,1.02-(Powers and Guertler, 1995 3).58)和未做影像检查(1.91,1.02-(Powers and Guertler, 1995 3).58)与30天联合不良事件独立相关。

适用人群与场景

  • 西班牙52家急诊科一周期间就诊的≥65岁患者。
  • 纳入标准:诊断为非特异性腹痛并在急诊诊疗后离院回家。

研究设计与关键结果

  • 研究类型:EDEN-43研究,纳入西班牙52家急诊科一周期间≥65岁、诊断为非特异性腹痛并离院回家的患者共397例(占同期离院老年患者的2.1%)。
  • 7天和30天全因死亡率分别为0.3%和1.5%。
  • 30天急诊再就诊率21.9%,30天住院率16.4%。
  • 30天联合不良事件(急诊再就诊、住院或死亡)为22.9%。
  • 30天联合不良事件独立 associated with 合并症和功能受损(Barthel指数<100分;2.35,1.24-4.45)。
  • 使用阿片类镇痛药(3.25,1.18-8.93)和非阿片类镇痛药(1.77,0.101-(Powers and Guertler, 1995 3).11)与30天联合不良事件独立相关。
  • 急诊期间未做实验室检查(1.91,1.02-(Powers and Guertler, 1995 3).58)和未做影像检查(1.91,1.02-(Powers and Guertler, 1995 3).58)与30天联合不良事件独立相关。
  • 年龄、性别和延长急诊观察与不良事件风险无关。

证据类型、等级与局限

  • 证据类型:多中心队列研究(52家西班牙急诊科)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,老年非特异性腹痛患者急诊离院应谨慎,尤其对合并症多、功能受限(Barthel指数<100分)、需要镇痛以及离院前未做实验室和影像检查的患者。
  • 年龄、性别和延长急诊观察与不良事件风险无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To determine the frequency of the diagnosis of NSAP among elderly patients discharged from EDs, investigate short-term outcomes and look for factors related to adverse outcomes.

OUTCOME MEASURES AND ANALYSIS: We included all patients 65 years or older diagnosed with NSAP and discharged home after ED care in 52 Spanish EDs during a one-week period. Outcomes consisted of 7-day and 30-day all-cause death, 30-day ED reconsultation and hospitalization, and 30-day combined adverse events (AEs) (ED reconsultation, hospitalization or death).

MAIN RESULTS: Among 25,557 elderly patients attended in EDs during the 1-week period, 19,026 were discharged home and 397 (2.1 %) had NSAP as the final diagnosis. The 7-day and 30-day mortality were 0. 3% and 1.5 %, respectively. The 30-day ED reconsultation was 21.9 % and the 30-day hospitalization was 16.4 %. Thirty-day combined AEs were recorded in 22.9 % of patients and were independently associated with comorbidity and functional impairment (Barthel index <100 points; 2.35, 1. 24-4.45), as well as the use of opiate (3.25, 1. 18-8.93) and non-opiate analgesia (1.77,0.101-(Powers and Guertler, 1995 3).11), and lack of laboratory (1.91, 1.02-(Powers and Guertler, 1995 3).58) and imaging (1.91, 1.02-(Powers and Guertler, 1995 3).58) studies in the ED during the index episode. Age, sex and extended ED observation were not associated with the risk of AEs.

CONCLUSIONS: A diagnosis of NSAP at ED discharge is frequent in elderly patients and carries a risk of adverse short-term outcomes. ED discharge of elderly patients with NSAP should be cautious, especially in comorbid patients with limited functional capacity, those needing analgesia, and patients discharged without laboratory and imaging studies.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Miró Ò, Morales X, Cuerpo S, et al. Non-specific abdominal pain in elderly patients discharged from the emergency department: Frequency, outcomes and risk-factors for adverse events (EDEN-43 study). Am J Emerg Med. 2025. PMID: 40203496. doi:10.1016/j.ajem.2025.04.007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。